| Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study … M Dinis-Ribeiro, M Areia, AC De Vries, R Marcos-Pinto, ... Endoscopy 44 (01), 74-94, 2012 | 1051 | 2012 |
| Treatment of Helicobacter pylori Infection 2010 A O’Connor, JP Gisbert, D McNamara, C O’Morain Helicobacter 15, 46-52, 2010 | 416* | 2010 |
| Sequential therapy for Helicobacter pylori eradication: a critical review JP Gisbert, X Calvet, A O'Connor, F Megraud, CA O'Morain Journal of clinical gastroenterology 44 (5), 313-325, 2010 | 311 | 2010 |
| Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a … SA Taylor, S Mallett, G Bhatnagar, R Baldwin-Cleland, S Bloom, A Gupta, ... The lancet Gastroenterology & hepatology 3 (8), 548-558, 2018 | 244 | 2018 |
| Population screening and treatment of Helicobacter pylori infection A O'connor, CA O'morain, AC Ford Nature Reviews Gastroenterology & Hepatology 14 (4), 230-240, 2017 | 211 | 2017 |
| Emerging treatments for inflammatory bowel disease K Hazel, A O’Connor Therapeutic advances in chronic disease 11, 2040622319899297, 2020 | 202 | 2020 |
| Improving compliance with Helicobacter pylori eradication therapy: when and how? JPA O'Connor, I Taneike, C O'Morain Therapeutic advances in gastroenterology 2 (5), 273-279, 2009 | 143 | 2009 |
| Sedation in digestive endoscopy: the Athens international position statements LB Cohen, SD Ladas, JJ Vargo, GA Paspatis, DJ Bjorkman, ... Alimentary pharmacology & therapeutics 32 (3), 425-442, 2010 | 112 | 2010 |
| Review – Treatment of Helicobacter pylori infection 2020 A O'Connor, T Furuta, JP Gisbert, C O'Morain Helicobacter 25, e12743, 2020 | 104 | 2020 |
| Impact of mucosal inflammation on risk of colorectal neoplasia in patients with ulcerative colitis: a systematic review and meta-analysis BM Flores, A O’Connor, AC Moss Gastrointestinal endoscopy 86 (6), 1006-1011. e8, 2017 | 101 | 2017 |
| Treatment of Helicobacter pylori Infection 2014 A O'Connor, D Vaira, JP Gisbert, C O'Morain Helicobacter 19, 38-45, 2014 | 98* | 2014 |
| European Society of Pathology; Sociedade Portuguesa de Endoscopia Digestiva. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the … M Dinis-Ribeiro, M Areia, AC De Vries, R Marcos-Pinto, ... Endoscopy 44 (1), 74-94, 2012 | 98 | 2012 |
| Treatment of Helicobacter pylori infection 2012 B Tepes, A O'Connor, JP Gisbert, C O'Morain Helicobacter 17, 36-42, 2012 | 96 | 2012 |
| Gastrointestinal side effects of cancer treatments M O’Reilly, G Mellotte, B Ryan, A O’Connor Therapeutic advances in chronic disease 11, 2040622320970354, 2020 | 91 | 2020 |
| Treatment of Helicobacter pylori infection in 2018 NR O'Morain, MP Dore, AJP O'Connor, JP Gisbert, CA O'Morain Helicobacter 23, e12519, 2018 | 84 | 2018 |
| Digestive function of the stomach A O'Connor, C O'Moráin Digestive diseases 32 (3), 186-191, 2014 | 84 | 2014 |
| Treatment of Helicobacter pylori infection 2017 A O'Connor, D Lamarque, JP Gisbert, C O'Morain Helicobacter 22, e12410, 2017 | 79 | 2017 |
| Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland A O'connor, I Taneike, A Nami, N Fitzgerald, P Murphy, B Ryan, ... European journal of gastroenterology & hepatology 22 (9), 1123-1127, 2010 | 60 | 2010 |
| Analysis of drug resistance and virulence‐factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status? I Taneike, A Nami, A O’connor, N Fitzgerald, P Murphy, A Qasim, ... Alimentary pharmacology & therapeutics 30 (7), 784-790, 2009 | 60 | 2009 |
| Systematic review and network meta-analysis of medical therapies to prevent recurrence of post-operative Crohn’s disease NE Burr, B Hall, PJ Hamlin, CP Selinger, AC Ford, A O’Connor Journal of Crohn's and Colitis 13 (6), 693-701, 2019 | 58 | 2019 |
